Literature DB >> 22914369

Case of infantile onset spinocerebellar ataxia type 5.

Francois-Dominique Jacob1, Eugenia S Ho, Mayra Martinez-Ojeda, Basil T Darras, Omar S Khwaja.   

Abstract

Dominant spinocerebellar ataxias are a rare clinically and genetically heterogeneous group of neurodegenerative disorders. They are characterized by progressive cerebellar ataxia resulting in unsteady gait, clumsiness, dysarthria, and swallowing difficulty. The onset of symptoms is usually in the third or fourth decade of life; however, more subtle clinical manifestations can start in early childhood. Spinocerebellar ataxia type 5, a dominant spinocerebellar ataxia associated with mutations involving β-III spectrin (SPTBN2), has been described in 3 families. It typically consists of a slowly progressive spinocerebellar ataxia with onset in the third decade. The authors present the first case of infantile-onset spinocerebellar ataxia associated with a novel SPTBN2 mutation (transition C>T at nucleotide position 1438), the proband having a much more severe phenotype with global developmental delay, hypotonia, tremor, nystagmus, and facial myokymia.

Entities:  

Keywords:  SPTBN2; spinocerebellar ataxia; β-III spectrin

Mesh:

Substances:

Year:  2012        PMID: 22914369     DOI: 10.1177/0883073812454331

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  16 in total

Review 1.  Using the shared genetics of dystonia and ataxia to unravel their pathogenesis.

Authors:  Esther A R Nibbeling; Cathérine C S Delnooz; Tom J de Koning; Richard J Sinke; Hyder A Jinnah; Marina A J Tijssen; Dineke S Verbeek
Journal:  Neurosci Biobehav Rev       Date:  2017-01-28       Impact factor: 8.989

2.  Between SCA5 and SCAR14: delineation of the SPTBN2 p.R480W-associated phenotype.

Authors:  Sara Nuovo; Alessia Micalizzi; Stefano D'Arrigo; Monia Ginevrino; Tommaso Biagini; Tommaso Mazza; Enza Maria Valente
Journal:  Eur J Hum Genet       Date:  2018-05-25       Impact factor: 4.246

3.  A Japanese SCA5 family with a novel three-nucleotide in-frame deletion mutation in the SPTBN2 gene: a clinical and genetic study.

Authors:  Ying Wang; Kishin Koh; Michiaki Miwa; Nobuo Yamashiro; Kazumasa Shindo; Yoshihisa Takiyama
Journal:  J Hum Genet       Date:  2014-08-21       Impact factor: 3.172

4.  Autosomal dominant SCA5 and autosomal recessive infantile SCA are allelic conditions resulting from SPTBN2 mutations.

Authors:  Solaf M Elsayed; Raoul Heller; Michaela Thoenes; Maha S Zaki; Daniel Swan; Ezzat Elsobky; Christine Zühlke; Inga Ebermann; Gudrun Nürnberg; Peter Nürnberg; Hanno J Bolz
Journal:  Eur J Hum Genet       Date:  2013-07-10       Impact factor: 4.246

5.  Mutant β-III spectrin causes mGluR1α mislocalization and functional deficits in a mouse model of spinocerebellar ataxia type 5.

Authors:  Karen R Armbrust; Xinming Wang; Tyisha J Hathorn; Samuel W Cramer; Gang Chen; Tao Zu; Takashi Kangas; Anastasia N Zink; Gülin Öz; Timothy J Ebner; Laura P W Ranum
Journal:  J Neurosci       Date:  2014-07-23       Impact factor: 6.167

6.  β-III-spectrin spinocerebellar ataxia type 5 mutation reveals a dominant cytoskeletal mechanism that underlies dendritic arborization.

Authors:  Adam W Avery; David D Thomas; Thomas S Hays
Journal:  Proc Natl Acad Sci U S A       Date:  2017-10-16       Impact factor: 11.205

Review 7.  A Novel Homozygous Mutation in SPTBN2 Leads to Spinocerebellar Ataxia in a Consanguineous Family: Report of a New Infantile-Onset Case and Brief Review of the Literature.

Authors:  Mohammad A Al-Muhaizea; Faten AlMutairi; Rawan Almass; Safinaz AlHarthi; Mazhor S Aldosary; Maysoon Alsagob; Ali AlOdaib; Dilek Colak; Namik Kaya
Journal:  Cerebellum       Date:  2018-06       Impact factor: 3.847

8.  De novo point mutations in patients diagnosed with ataxic cerebral palsy.

Authors:  Ricardo Parolin Schnekenberg; Emma M Perkins; Jack W Miller; Wayne I L Davies; Maria Cristina D'Adamo; Mauro Pessia; Katherine A Fawcett; David Sims; Elodie Gillard; Karl Hudspith; Paul Skehel; Jonathan Williams; Mary O'Regan; Sandeep Jayawant; Rosalind Jefferson; Sarah Hughes; Andrea Lustenberger; Jiannis Ragoussis; Mandy Jackson; Stephen J Tucker; Andrea H Németh
Journal:  Brain       Date:  2015-05-16       Impact factor: 13.501

9.  Pathogenic SPTBN1 variants cause an autosomal dominant neurodevelopmental syndrome.

Authors:  Margot A Cousin; Blake A Creighton; Keith A Breau; Rebecca C Spillmann; Erin Torti; Sruthi Dontu; Swarnendu Tripathi; Deepa Ajit; Reginald J Edwards; Simone Afriyie; Julia C Bay; Kathryn M Harper; Alvaro A Beltran; Lorena J Munoz; Liset Falcon Rodriguez; Michael C Stankewich; Richard E Person; Yue Si; Elizabeth A Normand; Amy Blevins; Alison S May; Louise Bier; Vimla Aggarwal; Grazia M S Mancini; Marjon A van Slegtenhorst; Kirsten Cremer; Jessica Becker; Hartmut Engels; Stefan Aretz; Jennifer J MacKenzie; Eva Brilstra; Koen L I van Gassen; Richard H van Jaarsveld; Renske Oegema; Gretchen M Parsons; Paul Mark; Ingo Helbig; Sarah E McKeown; Robert Stratton; Benjamin Cogne; Bertrand Isidor; Pilar Cacheiro; Damian Smedley; Helen V Firth; Tatjana Bierhals; Katja Kloth; Deike Weiss; Cecilia Fairley; Joseph T Shieh; Amy Kritzer; Parul Jayakar; Evangeline Kurtz-Nelson; Raphael A Bernier; Tianyun Wang; Evan E Eichler; Ingrid M B H van de Laar; Allyn McConkie-Rosell; Marie T McDonald; Jennifer Kemppainen; Brendan C Lanpher; Laura E Schultz-Rogers; Lauren B Gunderson; Pavel N Pichurin; Grace Yoon; Michael Zech; Robert Jech; Juliane Winkelmann; Adriana S Beltran; Michael T Zimmermann; Brenda Temple; Sheryl S Moy; Eric W Klee; Queenie K-G Tan; Damaris N Lorenzo
Journal:  Nat Genet       Date:  2021-07-01       Impact factor: 41.307

10.  A human β-III-spectrin spinocerebellar ataxia type 5 mutation causes high-affinity F-actin binding.

Authors:  Adam W Avery; Jonathan Crain; David D Thomas; Thomas S Hays
Journal:  Sci Rep       Date:  2016-02-17       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.